The FDA has unexpectedly canceled its annual meeting to decide on the strains for next season's influenza vaccines, causing confusion and concern among health officials. Dr. Paul Offit, an adviser on the panel, expressed that the meeting's cancellation leaves unanswered questions about the future of flu vaccines. This meeting is crucial for determining the vaccine strains based on predictions from the World Health Organization, and the timing is significant because production requires approximately six months prior to the vaccine rollout in September.
Because the vaccine is grown , for the most part, it requires six months to produce. So March is six months before September, which is when these vaccines roll out.
We're all left trying to understand what is going on. Why was this meeting canceled? It's an important meeting. What's the plan for flu vaccines this year.
Collection
[
|
...
]